CRT 2023
Atherosclerosis and Vulnerable Plaque
David Erlinge, MD, PhD (he/him/his)
Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden
Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)
Biljana Parapid, MD, PhD (she/her/hers)
Assistant Professor, Department of Medicine - Cardiology
Belgrade University School of Medicine
Belgrade, Serbia
No relationships to disclose
Allen J. Taylor, MD
Chairman of Cardiology
MedStar Heart and Vascular Institute
Washington, District of Columbia, United States
Disclosure(s): Amgen: Speakers' Bureau (Ongoing); Espirion: Speakers' Bureau (Ongoing)
Ron Waksman, MD, MSCAI
Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States
Disclosure information not submitted.
Fernando Alfonso, MD
Head, Department of Cardiology
Hospital Univeritario La Princesa, Madrid
Disclosure information not submitted.
James A. Goldstein, MD, FSCAI
Director, Research and Education
Beaumont Health System
Royal Oak, Michigan, United States
Disclosure(s): ECLS, Inc which licenses radiation shiled technology to Image Diagnostics, Inc: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Officer or Board Member (Ongoing), Royalties (Ongoing)
Paul A. Gurbel, MD, FSCAI
Director
Sinai Center for Thrombosis Research and Drug Development
Baltimore, Maryland, United States
Disclosure(s): Werfen: Grant/Research Support (Ongoing)
Peter Libby, MD (he/him/his)
Cardiovascular Specialist
Brigham and Women's Hospital
Boston, Massachusetts, United States
Disclosure(s): Amgen: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); AstraZeneca: unpaid consultant to, or involved in clinical trials for (Ongoing); Baim Institute for Clinical Research: unpaid consultant to, or involved in clinical trials for (Ongoing); Beren Therapeutics: unpaid consultant to, or involved in clinical trials for (Ongoing); Caristo Diagnostics: Scientific Advisory Board (Ongoing); Cartesian Therapeutics: Scientific Advisory Board (Ongoing); CSL Behring: Scientific Advisory Board (Ongoing); DalCor Pharmaceuticals: Scientific Advisory Board (Ongoing); Dewpoint Therapeutics: Scientific Advisory Board (Ongoing); Esperion Therapeutics: unpaid consultant to, or involved in clinical trials for (Ongoing); Genentech: unpaid consultant to, or involved in clinical trials for (Ongoing); Kancera: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Kowa Pharmaceuticals: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); MedImmune: Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Merck: unpaid consultant to, or involved in clinical trials for (Ongoing); Norvo Nordisk: unpaid consultant to, or involved in clinical trials for (Ongoing); Novartis: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Scientific Advisory Board (Ongoing), unpaid consultant to, or involved in clinical trials for (Ongoing); Olatec Therapeutics: Scientific Advisory Board (Ongoing); Pfizer: unpaid consultant to, or involved in clinical trials for (Ongoing); PlaqueTec Ltd: Scientific Advisory Board (Ongoing); Sanofi-Regeneron: unpaid consultant to, or involved in clinical trials for (Ongoing); Soley Thereapeutics: Scientific Advisory Board (Ongoing); TenSixteen Bio: Scientific Advisory Board (Ongoing); XBiotech, Inc.: Board Member (Ongoing)
Seth S. Martin, MD, MHS, FACC, FAHA, FASPC
Associate Professor
Johns Hopkins
Reisterstown, Maryland, United States
Disclosure(s): Amgen, Sanofi/Regeneron, Esperion, Novo Nordisk, Akcea: Scientific Advisory Board (Ongoing); Novartis Pharmaceuticals: Scientific Advisory Board (Ongoing)
Gregg W. Stone, MD, FACC, MSCAI (he/him/his)
Physician
Mount Sinai
New York, New York, United States
Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)
Deepak Talreja, MD
Director of Cath Lab/ Asst Professor
Sentara
Virgina Beach, Virginia, United States
Disclosure(s): AstraZeneca Pharmaceuticals: Speakers' Bureau (Ongoing); AstraZeneca, Bayer, CSL Behring, Janssen Pharmaceuticals, Merck, Osprey Medical, Watermark Reserach: Speakers' Bureau (Ongoing); Janssen Pharmaceuticals, Osprey Medical, Watermark Research Partners, Medscape: Speakers' Bureau (Ongoing); Medtronic: Honoraria (Ongoing), Speakers' Bureau (Ongoing); Pfizer-Bristol Myers Squibb alliance: Speakers' Bureau (Ongoing)